MUSC Reports on CDC’s ‘Overcoming COVD-19’ Observational Study Indicating Rare but Severe Pediatric Risks in Children & Young Adults

MUSC Reports on CDC’s ‘Overcoming COVD-19’ Observational Study Indicating Rare but Severe Pediatric Risks in Children & Young Adults

The” Overcoming COVID-19” study sponsored by the Centers for Disease Control and Prevention (CDC) included dozens of prominent academic medical centers in a study to track and characterize the development of complications in children and young adults as a result of exposure to COVID-19, including Multisystem Inflammatory Syndrome in Children (MIS-C). The study team set up real-time surveillance, reporting, and prospective enrollment of study subjects and associated respiratory and blood samples. The goal: better understand the risk factors and outcomes associated with COVID-19 critical illness in the pediatric population and clarify complications found in younger populations thought to be associated with COVID-19. Finally, the study was designed to identify these complications’ predictive markers while characterizing the development and maintenance of adaptive immunity. TrialSite shares some of the key results below. While only a small percentage of COVID-19 cases involving children or young adults end up severe, it does happen. While overall rare, in a small percentage of cases, severe COVID-19 leads to significant problems. Among this group experiencing severe problems, 22%...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee